Subscribe for unlimited access to DynaMed content, CME/CE & MOC credit, and email alerts on content you follow.

Already subscribed? Sign in now

Learn more about CME

Percutaneous Coronary Intervention (PCI) Procedure

MoreVert
AddCircleOutlineFollow
ShareShare
AddCircleOutlineFollow
Follow
ShareShare
Share

You must be a subscriber to see the full topic content.

  • KeyboardArrowRight

    Overview and Recommendations

    • Background

    • Evaluation

    • KeyboardArrowRight

      Management

      • Preprocedural management

      • Procedural considerations

      • Postprocedural considerations

  • Related Summaries

  • Overview

  • Description

  • Definitions

  • Indications

  • Description of Procedure

  • KeyboardArrowRight

    Adjunctive Procedures

    • KeyboardArrowRight

      Thrombus aspiration or thrombectomy

    • Coronary atherectomy

  • Coronary stenting

  • KeyboardArrowRight

    Adjunctive Devices

    • Embolic protection devices

    • Hemodynamic support devices

    • Vascular closure devices

  • KeyboardArrowRight

    Procedural Variations

    • Considerations for choice of approach

    • Radial artery approach evidence

    • Other procedural variations

  • Adjunctive Imaging and Diagnostic Devices

  • KeyboardArrowRight

    Periprocedural Management

    • KeyboardArrowRight

      Periprocedural medications

      • Antiplatelet and anticoagulant drugs

      • Statins

      • Other periprocedural medications

    • Prevention of contrast media-related complications

    • Remote ischemic conditioning

    • Stress reduction strategies

    • Other alternative treatments

    • KeyboardArrowRight

      Bleeding

      • Bleeding risk

      • Bleeding score

  • KeyboardArrowRight

    Post-revascularization Management

    • Myocardial infarction assessment

    • Same-day discharge

    • KeyboardArrowRight

      Postprocedural medications

      • KeyboardArrowRight

        Recommendations from professional organizations

        • American College of Cardiology Foundation/American Heart Association/Society for Cardiovascular Angiography (ACCF/AHA/SCAI) 2016 guidelines

        • European Society of Cardiology (ESC) 2017 recommendations on dual antiplatelet therapy (DAPT) in coronary artery disease

        • American College of Chest Physicians (ACCP) 2012 guidelines

      • Postprocedural medications

    • Management of restenosis

    • Follow-up cardiac evaluation

    • KeyboardArrowRight

      Additional management

      • Screening for depression

      • Exercise recommendations

      • Smoking cessation

  • KeyboardArrowRight

    Quality Improvement

    • Physician Quality Reporting System Quality Measures

    • American College of Cardiology Foundation/American Heart Association/Society for Cardiovascular Angiography and Interventions (ACCF/AHA/SCAI) recommendations

    • American College of Cardiology (ACC)/American Heart Association (AHA) Performance Measures

    • Criteria for operators and facilities providing PCI

    • Effects of facility and provider experience

  • KeyboardArrowRight

    Guidelines and Resources

    • KeyboardArrowRight

      Guidelines

      • United States guidelines

      • European guidelines

      • Asian guidelines

      • Central and South American guidelines

      • Australian and New Zealand guidelines

    • Review articles

  • Patient Information

  • KeyboardArrowRight

    References

    • General references used

    • Recommendation grading systems used

    • Synthesized Recommendation Grading System for DynaMed

    • DynaMed Editorial Process

    • Special acknowledgements

    • How to cite

Recommendations Editor
Esther Jolanda van Zuuren MD
KeyboardArrowDown
Affiliations

Head of Allergy, Dermatology, and Venereology, Leiden University Medical Centre; Netherlands

Conflicts of Interest

Dr. van Zuuren declares no relevant financial conflicts of interest.

Deputy Editor
Peter Oettgen MD
KeyboardArrowDown
Affiliations

Editor in Chief, DynaMed; Cardiologist, Beth Israel Deaconess Medical Center; Massachusetts, United States; Associate Professor of Medicine, Harvard Medical School; Massachusetts, United States

Conflicts of Interest

Dr. Oettgen declares no relevant financial conflicts of interest.

CheckCircle

top